Comparing nerve-sparing surgery for prostate cancer recovery
Part of Cancer, Kidney & urinary clinical trials.
This trial compares two nerve-sparing surgery techniques for prostate cancer to see which one better protects urinary control and sexual function while still removing the cancer. It may help men with early-stage prostate cancer who are planning to have robotic surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man aged 18 to 80.
- You have prostate cancer that has not spread beyond the prostate (early stage).
- Your cancer is considered low or intermediate risk by standard guidelines.
- You are generally healthy and able to care for yourself (ECOG score 0 or 1).
- You are expected to live at least 10 more years.
- You have not had any previous treatment for prostate cancer, such as surgery, hormone therapy, or radiation.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how your health before surgery affects your erectile function after robot-assisted prostate removal. It aims to help doctors predict and improve recovery of erectile function.
This study tests whether using a special ultrasound tool during prostate cancer surgery helps protect the nerves that control erections. If you have good erectile function and are scheduled for nerve-sparing prostate removal, this trial may be a good fit for you.
This trial tests if a nerve grafting technique can help preserve erectile function after robotic surgery for high-risk localized prostate cancer. It may be an option for men with good preoperative erectile function.
This study tests whether using special MRI scans to map nerves before surgery helps keep erectile function after prostate removal. It may help men who are having surgery for prostate cancer and want to preserve sexual function.
This study looks at a robotic prostate operation that aims to remove only the affected side while keeping the urethra (the tube for urination) to help preserve urinary function. It’s for people with low- to intermediate-risk, one-sided prostate cancer and no spread to lymph nodes, bones, or other organs.
This trial compares two surgical approaches for removing lymph nodes during prostate cancer surgery in men with high-risk disease on one side of the prostate. The goal is to determine whether removing lymph nodes from both sides or just one side provides better outcomes.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.